Summary

Venous Stents Market – Scope of Report
TMR’s report on the global Venous Stents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global Venous Stents market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Venous Stents market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Venous Stents market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Venous Stents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Venous Stents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Venous Stents market.

The report delves into the competitive landscape of the global Venous Stents market. Key players operating in the global Venous Stents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Venous Stents market profiled in this report.

Key Questions Answered in Global Venous Stents Market Report
• What is the sales/revenue generated by Venous Stents across all regions during the forecast period?
• What are the opportunities in the global Venous Stents market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Venous Stents Market – Research Objectives and Research Approach
The comprehensive report on the global Venous Stents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Venous Stents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Venous Stents market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Venous Stents Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Venous Stents Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Epidemiology of Venous Diseases
5.2. Product Mapping: Venous Stents
5.3. Clinical Trial Analysis
5.4. Regulatory Landscape for Venous Stents in Key Regions / Countries
5.5. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers and Acquisitions, Funding and investments)
5.6. Impact of COVID-19 Pandemic
6. Global Venous Stents Market Analysis and Forecasts, By Technology
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Stent Design, 2020-2034
6.3.1. Iliac Vein Stent Technology
6.3.2. Wallstent Technology
6.3.3. Others
6.4. Market Attractiveness By Technology
7. Global Venous Stents Market Analysis and Forecasts, By Material
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Material, 2020-2034
7.3.1. Nitinol
7.3.2. Elgiloy
7.3.3. Stainless Steel
7.4. Market Attractiveness By Material
8. Global Venous Stents Market Analysis and Forecasts, By Stent Design
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Stent Design, 2020-2034
8.3.1. Braided
8.3.2. Laser-cut
8.3.3. Open-cell
8.3.4. Closed-cell
8.4. Market Attractiveness By Stent Design
9. Global Venous Stents Market Analysis and Forecasts, By Placement of Stent
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Placement of Stent, 2020-2034
9.3.1. Lower Limbs
9.3.2. Thorax
9.3.3. Abdomen
9.3.4. Upper Limbs
9.4. Market Attractiveness By Placement of Stent
10. Global Venous Stents Market Analysis and Forecasts, By Indication
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast By Indication, 2020-2034
10.3.1. Chronic Deep Vein Thrombosis
10.3.2. Post Thrombotic Syndrome
10.3.3. May-Thurner Syndrome
10.3.4. Nutcracker Syndrome
10.3.5. Hemodialysis / Arteriovenous Fistulae
10.3.6. Others
10.4. Market Attractiveness By Indication
11. Global Venous Stents Market Analysis and Forecasts, By End-user
11.1. Introduction & Definition
11.2. Key Findings / Developments
11.3. Market Value Forecast By End-user, 2020-2034
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Specialty Centers
11.3.4. Others
11.4. Market Attractiveness By End-user
12. Global Venous Stents Market Analysis and Forecasts, By Region
12.1. Key Findings
12.2. Market Value Forecast By Region
12.2.1. North America
12.2.2. Europe
12.2.3. Asia Pacific
12.2.4. Latin America
12.2.5. Middle East & Africa
12.3. Market Attractiveness By Region
13. North America Venous Stents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Technology, 2020-2034
13.2.1. Iliac Vein Stent Technology
13.2.2. Wallstent Technology
13.2.3. Others
13.3. Market Value Forecast By Material, 2020-2034
13.3.1. Nitinol
13.3.2. Elgiloy
13.3.3. Stainless Steel
13.4. Market Value Forecast By Stent Design, 2020-2034
13.4.1. Braided
13.4.2. Laser-cut
13.4.3. Open-cell
13.4.4. Closed-cell
13.5. Market Value Forecast By Placement of Stent, 2020-2034
13.5.1. Lower Limbs
13.5.2. Thorax
13.5.3. Abdomen
13.5.4. Upper Limbs
13.6. Market Value Forecast By Indication, 2020-2034
13.6.1. Chronic Deep Vein Thrombosis
13.6.2. Post Thrombotic Syndrome
13.6.3. May-Thurner Syndrome
13.6.4. Nutcracker Syndrome
13.6.5. Hemodialysis / Arteriovenous Fistulae
13.6.6. Others
13.7. Market Value Forecast By End-user, 2020-2034
13.7.1. Hospitals
13.7.2. Ambulatory Surgical Centers
13.7.3. Specialty Centers
13.7.4. Others
13.8. Market Value Forecast By Country, 2020-2034
13.8.1. U.S.
13.8.2. Canada
13.9. Market Attractiveness Analysis
13.9.1. By Technology
13.9.2. By Material
13.9.3. By Stent Design
13.9.4. By Placement of Stent
13.9.5. By Indication
13.9.6. By End-user
13.9.7. By Country
14. Europe Venous Stents Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Technology, 2020-2034
14.2.1. Iliac Vein Stent Technology
14.2.2. Wallstent Technology
14.2.3. Others
14.3. Market Value Forecast By Material, 2020-2034
14.3.1. Nitinol
14.3.2. Elgiloy
14.3.3. Stainless Steel
14.4. Market Value Forecast By Stent Design, 2020-2034
14.4.1. Braided
14.4.2. Laser-cut
14.4.3. Open-cell
14.4.4. Closed-cell
14.5. Market Value Forecast By Placement of Stent, 2020-2034
14.5.1. Lower Limbs
14.5.2. Thorax
14.5.3. Abdomen
14.5.4. Upper Limbs
14.6. Market Value Forecast By Indication, 2020-2034
14.6.1. Chronic Deep Vein Thrombosis
14.6.2. Post Thrombotic Syndrome
14.6.3. May-Thurner Syndrome
14.6.4. Nutcracker Syndrome
14.6.5. Hemodialysis / Arteriovenous Fistulae
14.6.6. Others
14.7. Market Value Forecast By End-user, 2020-2034
14.7.1. Hospitals
14.7.2. Ambulatory Surgical Centers
14.7.3. Specialty Centers
14.7.4. Others
14.8. Market Value Forecast By Country / Sub-region, 2020-2034
14.8.1. Germany
14.8.2. U.K.
14.8.3. France
14.8.4. Spain
14.8.5. Italy
14.8.6. Rest of Europe
14.9. Market Attractiveness Analysis
14.9.1. By Technology
14.9.2. By Material
14.9.3. By Stent Design
14.9.4. By Placement of Stent
14.9.5. By Indication
14.9.6. By End-user
14.9.7. By Country / Sub-region
15. Asia Pacific Venous Stents Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Technology, 2020-2034
15.2.1. Iliac Vein Stent Technology
15.2.2. Wallstent Technology
15.2.3. Others
15.3. Market Value Forecast By Material, 2020-2034
15.3.1. Nitinol
15.3.2. Elgiloy
15.3.3. Stainless Steel
15.4. Market Value Forecast By Stent Design, 2020-2034
15.4.1. Braided
15.4.2. Laser-cut
15.4.3. Open-cell
15.4.4. Closed-cell
15.5. Market Value Forecast By Placement of Stent, 2020-2034
15.5.1. Lower Limbs
15.5.2. Thorax
15.5.3. Abdomen
15.5.4. Upper Limbs
15.6. Market Value Forecast By Indication, 2020-2034
15.6.1. Chronic Deep Vein Thrombosis
15.6.2. Post Thrombotic Syndrome
15.6.3. May-Thurner Syndrome
15.6.4. Nutcracker Syndrome
15.6.5. Hemodialysis / Arteriovenous Fistulae
15.6.6. Others
15.7. Market Value Forecast By End-user, 2020-2034
15.7.1. Hospitals
15.7.2. Ambulatory Surgical Centers
15.7.3. Specialty Centers
15.7.4. Others
15.8. Market Value Forecast By Country / Sub-region, 2020-2034
15.8.1. China
15.8.2. Japan
15.8.3. India
15.8.4. Australia & New Zealand
15.8.5. Rest of Asia Pacific
15.9. Market Attractiveness Analysis
15.9.1. By Technology
15.9.2. By Material
15.9.3. By Stent Design
15.9.4. By Placement of Stent
15.9.5. By Indication
15.9.6. By End-user
15.9.7. By Country / Sub-region
16. Latin America Venous Stents Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast By Technology, 2020-2034
16.2.1. Iliac Vein Stent Technology
16.2.2. Wallstent Technology
16.2.3. Others
16.3. Market Value Forecast By Material, 2020-2034
16.3.1. Nitinol
16.3.2. Elgiloy
16.3.3. Stainless Steel
16.4. Market Value Forecast By Stent Design, 2020-2034
16.4.1. Braided
16.4.2. Laser-cut
16.4.3. Open-cell
16.4.4. Closed-cell
16.5. Market Value Forecast By Placement of Stent, 2020-2034
16.5.1. Lower Limbs
16.5.2. Thorax
16.5.3. Abdomen
16.5.4. Upper Limbs
16.6. Market Value Forecast By Indication, 2020-2034
16.6.1. Chronic Deep Vein Thrombosis
16.6.2. Post Thrombotic Syndrome
16.6.3. May-Thurner Syndrome
16.6.4. Nutcracker Syndrome
16.6.5. Hemodialysis / Arteriovenous Fistulae
16.6.6. Others
16.7. Market Value Forecast By End-user, 2020-2034
16.7.1. Hospitals
16.7.2. Ambulatory Surgical Centers
16.7.3. Specialty Centers
16.7.4. Others
16.8. Market Value Forecast By Country / Sub-region, 2020-2034
16.8.1. Brazil
16.8.2. Mexico
16.8.3. Rest of Latin America
16.9. Market Attractiveness Analysis
16.9.1. By Technology
16.9.2. By Material
16.9.3. By Stent Design
16.9.4. By Placement of Stent
16.9.5. By Indication
16.9.6. By End-user
16.9.7. By Country / Sub-region
17. Middle East & Africa Venous Stents Market Analysis and Forecast
17.1. Introduction
17.1.1. Key Findings
17.2. Market Value Forecast By Technology, 2020-2034
17.2.1. Iliac Vein Stent Technology
17.2.2. Wallstent Technology
17.2.3. Others
17.3. Market Value Forecast By Material, 2020-2034
17.3.1. Nitinol
17.3.2. Elgiloy
17.3.3. Stainless Steel
17.4. Market Value Forecast By Stent Design, 2020-2034
17.4.1. Braided
17.4.2. Laser-cut
17.4.3. Open-cell
17.4.4. Closed-cell
17.5. Market Value Forecast By Placement of Stent, 2020-2034
17.5.1. Lower Limbs
17.5.2. Thorax
17.5.3. Abdomen
17.5.4. Upper Limbs
17.6. Market Value Forecast By Indication, 2020-2034
17.6.1. Chronic Deep Vein Thrombosis
17.6.2. Post Thrombotic Syndrome
17.6.3. May-Thurner Syndrome
17.6.4. Nutcracker Syndrome
17.6.5. Hemodialysis / Arteriovenous Fistulae
17.6.6. Others
17.7. Market Value Forecast By End-user, 2020-2034
17.7.1. Hospitals
17.7.2. Ambulatory Surgical Centers
17.7.3. Specialty Centers
17.7.4. Others
17.8. Market Value Forecast By Country / Sub-region, 2020-2034
17.8.1. GCC Countries
17.8.2. South Africa
17.8.3. Rest of Middle East & Africa
17.9. Market Attractiveness Analysis
17.9.1. By Technology
17.9.2. By Material
17.9.3. By Stent Design
17.9.4. By Placement of Stent
17.9.5. By Indication
17.9.6. By End-user
17.9.7. By Country / Sub-region
18. Competition Landscape
18.1. Market Player - Competition Matrix (By Tier and Size of companies)
18.2. Company Profiles
18.2.1. Becton, Dickinson, and Company (BD)
18.2.1.1. Company Overview
18.2.1.2. Financial Overview
18.2.1.3. Product Portfolio
18.2.1.4. Business Strategies
18.2.1.5. Recent Developments
18.2.2. Medtronic plc
18.2.2.1. Company Overview
18.2.2.2. Financial Overview
18.2.2.3. Product Portfolio
18.2.2.4. Business Strategies
18.2.2.5. Recent Developments
18.2.3. Boston Scientific Corporation
18.2.3.1. Company Overview
18.2.3.2. Financial Overview
18.2.3.3. Product Portfolio
18.2.3.4. Business Strategies
18.2.3.5. Recent Developments
18.2.4. Cook Medical
18.2.4.1. Company Overview
18.2.4.2. Financial Overview
18.2.4.3. Product Portfolio
18.2.4.4. Business Strategies
18.2.4.5. Recent Developments
18.2.5. Koninklijke Philips N.V.
18.2.5.1. Company Overview
18.2.5.2. Financial Overview
18.2.5.3. Product Portfolio
18.2.5.4. Business Strategies
18.2.5.5. Recent Developments
18.2.6. Bentley InnoMed GmbH
18.2.6.1. Company Overview
18.2.6.2. Financial Overview
18.2.6.3. Product Portfolio
18.2.6.4. Business Strategies
18.2.6.5. Recent Developments
18.2.7. W. L. Gore & Associates, Inc.
18.2.7.1. Company Overview
18.2.7.2. Financial Overview
18.2.7.3. Product Portfolio
18.2.7.4. Business Strategies
18.2.7.5. Recent Developments
18.2.8. optimed Medizinische Instrumente GmbH
18.2.8.1. Company Overview
18.2.8.2. Financial Overview
18.2.8.3. Product Portfolio
18.2.8.4. Business Strategies
18.2.8.5. Recent Developments
18.2.9. plus medica GmbH & Co. KG
18.2.9.1. Company Overview
18.2.9.2. Financial Overview
18.2.9.3. Product Portfolio
18.2.9.4. Business Strategies
18.2.9.5. Recent Developments
18.2.10. SUZHOU INNOMED MEDICAL DEVICE CO.,LTD
18.2.10.1. Company Overview
18.2.10.2. Financial Overview
18.2.10.3. Product Portfolio
18.2.10.4. Business Strategies
18.2.10.5. Recent Developments